Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

New Brain Health Guidelines

Navigating Perimenopause and Menopause – Managing Weight, Health and Wellbeing in General Practice

Autism & Mental Health Comorbidities

Pharmacogenomics in General Practice

expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis